Something is brewing beneath the surface, and the cleanup crew has already brought gloves.

When execution improves before attention arrives, the move tends to follow... but only when the market has finally priced in the punchline.

Don’t Let These Undervalued Stocks Slip Through Your Fingers!

We now send our favorite value picks via text, too, so you’ll get the same actionable news without having to open your inbox.

👉 Click here to get stock picks by text and uncover the best value opportunities!

Environmental Services

Montrose Environmental Group (NYSE: MEG) is giving us a clear reason to pay attention.

The stock is back in focus because earnings expectations are improving while the valuation remains grounded... a combination that rarely stays overlooked for long.

Earnings forecasts have been moving higher, pointing to a strengthening business outlook. Revisions often show up before price action, not after it.

You are seeing confidence build around Montrose’s ability to execute, rather than a narrative driven by hype or short-term noise.

MEG also holds up well across traditional value measures that disciplined market participants tend to respect, including earnings power and balance sheet support. 

This is not an overheated environmental name. You are looking at a company where expectations are rising, but the price has not fully adjusted yet.

Why the Valuation Gap Matters

Environmental services names often command premium pricing by default.

Montrose stands apart by combining improving fundamentals with a restrained valuation.

That gap is exactly what puts this stock back into focus.

What to Watch From Here

Upcoming earnings updates will matter more than commentary.

Execution will determine whether the valuation starts to reset at a higher level.

If expectations continue to improve, the setup becomes harder to ignore.

Healthcare

Liquidia Corp (NASDAQ: LQDA) is back in the spotlight after delivering a YUTREPIA update that gives you plenty to think about.

When a commercial-stage biotech starts showing real traction at the prescription level, the market pays attention, and so should you.

The stock’s recent run reflects that shift in tone. Strong price momentum over the past year tells you optimism around YUTREPIA is building. It is a commercialization story, and the numbers are starting to support that transition.

Valuation is where the debate heats up. Liquidia trades at a premium that assumes YUTREPIA continues to scale and losses narrow over time.

On a sales multiple basis, the stock screens as expensive relative to much of the pharmaceutical space. 

At the same time, longer-term valuation models suggest the current price may still be leaving upside on the table if execution stays on track.

Why the Multiple Looks Stretched

The current valuation reflects confidence in YUTREPIA becoming a durable franchise.

That confidence leaves less room for missteps along the way.

Any slowdown in uptake would likely be felt quickly in the share price.

What You Should Watch Next

Prescription growth will matter more than headline revenue.

Cash flow trends will shape how sustainability is viewed, but consistency is what turns momentum into credibility.

Financial Services

Circle Internet Group Inc (NYSE: CRCL) is hovering near recent lows, trying to shake off its post-IPO stumble. 

Here’s what matters most for anyone tracking the story. Circle is diversifying revenue, with subscription and services fees starting to drive growth while reducing reliance on interest income. 

Transaction-based flows and blockchain partnerships are starting to gain real traction, providing a platform that’s building a more sustainable foundation.

Expectations in the market are shifting, and that matters for your timing. Optimistic forecasts highlight potential upside, while broader adoption of digital asset infrastructure could fuel momentum further. 

CRCL isn’t just a post-IPO laggard anymore; it’s a platform trying to turn early promise into steady performance.

Revenue Diversification Supports Growth

Non-reserve revenue is now taking center stage.

Subscription and service fees provide a more reliable income stream for you to track.

This shift reduces dependency on interest income and strengthens the platform’s long-term story.

Market Sentiment Drives Attention

Expectations for CRCL remain wide-ranging, reflecting both volatility and potential.

Optimism around digital asset adoption continues to influence momentum, and you’ll want to note how it shapes short-term moves.

How the stock responds over the coming weeks will likely determine if a meaningful recovery takes hold.

US Foods Holding Corp (NYSE: USFD) is turning heads this week for all the right reasons. The stock is standing out because it pairs solid earnings growth with a valuation that looks appealing compared to peers.

With a PEG ratio comfortably below the industry average and a price-to-sales ratio well under typical levels, USFD is signaling that the market may be underestimating its earning power.

Beyond the numbers, the story is simple: the company’s fundamentals are strong, and the Value grade reflects a business trading below its potential.

If you’re looking for a stock where growth and valuation align, USFD is serving up a clear opportunity right now.

Celsius Holdings Inc. (NASDAQ: CELH) is outperforming major indices and leaving the Consumer Staples sector in its dust.

Momentum is building ahead of the upcoming earnings report, with expectations for both revenue and EPS growth signaling that the business is scaling fast. The story isn’t just growth on paper.

CELH trades at a premium valuation, reflecting confidence in its trajectory, while a PEG ratio below the industry average suggests earnings growth may justify the price. Positive estimate revisions and strong near-term projections show that the market is taking notice.

For you, this means Celsius isn’t just moving with the market... It’s leading it.

If the company meets expectations, momentum could accelerate, making CELH one to watch closely in the coming trading sessions.

Commercial Metals Co. (NYSE: CMC): For anyone following industrial growth stories, this stock is making a strong case.

You can see it in projected earnings growth that outpaces the industry and in how efficiently the company is turning assets into revenue.

Sales momentum and a superior S/TA ratio show that CMC is extracting more value from every dollar of assets. You’ll also want to note the upward revisions in earnings estimates, which reinforce confidence in near-term results.

Strong execution and smart capital allocation make this stock worth keeping on your radar as it aims to convert solid fundamentals into meaningful market performance.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you'd like us to dig into.

Best Regards,
—Noah Zelvis
Undervalued Edge